Abstract
The traditional outcome parameters employed in clinical research in oncology include tumor response, local recurrence rate, development of metastatic disease, disease-free and overall survival, and, in the case of palliative therapies, the control of major physical symptoms. Increasingly, however, there is interest in incorporating a broader set of evaluation criteria that reflect the impact of the disease and of its treatment on the functional, psychological, and social health of the individual patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaronson NK, Bullinger M, Ahmedzai S (1988) A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Res 111: 231–249
Aaronson NK, Bullinger M, Ahmedzai S et al. (1991) The EORTC core quality- of-life questionnaire: interim results of an international field study. In: Osoba D (ed) Effect of cancer on quality of life. CRC, London, pp 185–203
Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjödén P (1991) Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer 27:1075–1081
Bergner M, Bobbitt RA, Carter WB, Gilson BS (1981) The sickness impact profile: development and final revision of a health status measure. Med Care 19:787–805
Brunner KW (1989) Adjuvant therapies in breast cancer and quality of life: a critical review of the TWIST concept. Recent Results Cancer Res 115:239–243
Cairns J (1985) The treatment of disease and the war against cancer. Sci Am 253:31–39
Cassileth BR, Knuiman MW, Abeloff MD, Falkson G, Ezdinli EZ, Mehta CR (1986) Anxiety levels in patients randomized to adjuvant therapy versus observation for early breast cancer. J Clin Oncol 4:972–974
Cella DF, Tulsky DS (1990) Measuring quality of life today: methodological aspects. Oncology 4:29–38
Cella DF, Lee-Riordan D, Silberman M et al. (1989) Quality of life in advanced cancer: three new disease-specific measures (Abstr). Proc Am Soc Clin Oncol 8:315
Chambers LW, MacDonald LA, Tugwell P, Buchanan W, Kraag G (1982) The McMaster health index questionnaire as a measure of quality of life for patients with rheumatoid disease. J Rheumatol 9:780–784
De Haes JCJM, van Knippenberg FCE (1985) The quality of life of cancer patients: a review of the literature. Soc Sci Med 20:809–817
De Haes JCJM, van Knippenberg FCE, Neijt JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam symptom checklist. Br J Cancer 62:1034–1038
Fayers PM, Jones SDR (1983) Measuring and analyzing the quality of life in cancer clinical trials: a review. Stat Med 2:429–446
Feinstein AR (1987) Clinimetric perspectives. J Chronic Dis 40:635–640
Feldstein ML (1991) Quality-of-life-adjusted survival comparing cancer treatments. Cancer 67:851–854
Ganz PA, Polinsky MI, Schag CAC, Heinrich RL (1989) Rehabilitation of patients with primary breast cancer: assessing the impact of adjuvant therapy. Recent Results Cancer Res 115:244–254
Ganz PA, Coscarelli Schag CA, Cheng HL (1990) Assessing the quality of life - a study in newly diagnosed breast cancer patients. J Clin Epidemiol 43:75–86
Gelber RD, Goldhirsch A (1986) A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 4:1772–1779
Goldhirsch A, Gelber RD, Simes RJ, Glasziou P, Coates AS (1989) Costs and benefits of adjuvant therapy in breast cancer: a quality-adjust survival analysis. J Clin Oncol 7:36–44
Gough IR, Furnival CM, Schilder L, Grove W (1983) Assessment of the quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol 19:1161–1165
Guyatt G, Feeny D, Patrick D (1991) Issues in quality-of-life measurement in clinical trials. Controlled Clin Trials 12:81S–90S
Hughson AVM, Cooper AF, McArdle CS, Smith DC (1986) Psychological impact of adjuvant chemotherapy in the first two years after mastectomy. Br Med J 293:1268–1271
Hunt SM, McEwen J (1980) The development of a subjective health indicator. Sociol Health Jll 2:231–246
Hürny C, Bernhard J, Gelber RD et al. (1992) Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. Eur J Cancer (in press)
Hutchinson TA, Boyd NF, Feinstein AR (1979) Scientific problems in clinical scales as demonstrated by the Kamofsky index of performance status. J Chronic Dis 32:661–666
Irvine D, Brown B, Crooks D, Roberts J, Browne G (1991) Psychosocial adjustment in women with breast cancer. Cancer 67:1097–1117
Johnson JR, Temple R (1985) Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 69:1155–1157
Kaplan RM, Buksh JW (1982) Health-related quality of life measurement for evaluation research and policy analysis. J Healt Econ 5:1–30
Kiebert GM, de Haes JCJM, van de Velde CJH (1991) The impact of breast- conserving treatment and mastectomy on the quality of life of ealry-stage breast cancer patients: a review. J Clin Oncol 9:1059–1070
Knopf T (1990) Symptoms and rehabilitation needs of patients with early stage breast cancer during primary therapy. Cancer 66:1392–1401
Levine MN, Guyatt GH, Gent M et al. (1988) Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol 6:1798–1810
Love RR, Leventhal H, Easterling DV, Nerenz DR (1989) Side effects and emotional distress during cancer chemotherapy. Cancer 63:604–612
Maguire GP, Tait A, Brooke M, Thomas C (1980) Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy. Br Med J 281:1179–1180
Mcardle CS, Caiman KC, Cooper AF, Hughson AVM, Russell AR, Smith DC (1981) The social, emotional and financial implications of adjuvant chemotherapy in breast cancer. Br J Surg 68:261–264
Padilla GV, Presant C, Grant MM, Metter G, Lipsett J, Heide F (1983) Quality of life index for patients with Cancer. Res Nurs Health 6:117–126
Palmer BV, Walsh GA, McKinna JA, Greening WP (1980) Adjuvant chemotherapy for breast cancer: side effects and quality of life. Br Med J 281:1594–1597
Schag CC, Heinrich RL, Ganz PA (1984) Karnofsky performance status revisited: reliability, validity and guidelines. J Clin Oncol 2:187–193
Schipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the quality of life of cancer patients: the functional living index-cancer. J Clin Oncol 2:472–483
Selby PJ, Chapman JA, Etazadi-Amoli J, Dailey D, Boyd NF (1984) The development of a method of assessing the quality of life for cancer patients. Br J Cancer 50:13–22
Spitzer WO (1987) State of science 1986: quality of life and functional status as target variables for research. J Chronic Dis 40:473–480
Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR (1981) Measuring the quality of life cancer patients: a concise QL-index for use by physicians. J Chronic Dis 34:585–597
Stewart AL, Hays RD, Ware JE (1988) The MOS short-form general health survey: reliability and validity in a patient population. Med Care 26:724–735
Tamburini M, Brambilla C, Ferrari L, Bombino T, Gangeri L, Rosso S (1991) Two simple indexes used to evaluate the impact of therapy on the quality of life of patients receiving primary chemotherapy for operable breast cancer. Ann Oncol 2:417–422
Torrance GW (1986) Measurement of health state utilities for economic appraisal. J Health Econ 5:1–30
van Knippenberg FCE, de Haes JCJM (1988) Measuring the quality of life of cancer patients: psychometric properties of instruments. J Clin Epidemiol 41:1043–1053
Ware JE Jr (1984) Conceptualizing disease impact and treatment outcomes. Cancer 53:2216–2326
Ware JE Jr (1987) Standards for validating health measures: definitions and content. J Chronic Dis 40:473–480
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care (in press)
World Health Organization (1947) The constitution of the World Health Organization. WHO Chronicle 1:2
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Aaronson, N.K. (1993). Assessment of Quality of Life and Benefits from Adjuvant Therapies in Breast Cancer. In: Senn, HJ., Gelber, R.D., Goldhirsch, A., Thürlimann, B. (eds) Adjuvant Therapy of Breast Cancer IV. Recent Results in Cancer Research, vol 127. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84745-5_28
Download citation
DOI: https://doi.org/10.1007/978-3-642-84745-5_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84747-9
Online ISBN: 978-3-642-84745-5
eBook Packages: Springer Book Archive